GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Net Income Including Noncontrolling Interests

Zim Laboratories (BOM:541400) Net Income Including Noncontrolling Interests : ₹172 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zim Laboratories Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Zim Laboratories's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ₹81 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ₹172 Mil.

Zim Laboratories Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Zim Laboratories's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Net Income Including Noncontrolling Interests Chart

Zim Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.97 73.18 145.50 244.35 172.46

Zim Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.36 2.27 41.50 47.85 80.86

Zim Laboratories Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹172 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim Laboratories Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim Laboratories (BOM:541400) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
NSE:SAKAR BOM:540937 BOM:506414 BOM:532649 BOM:532305 BOM:524075 BOM:506260 BOM:540737 BOM:543329 BOM:524500 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZIMLAB:India
Address
Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Website
https://www.zimlab.in
Zim Laboratories Ltd is a pharmaceutical company. It is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Tadalafil, Vitamin D3, Levocetirizine, Methylcobalamin, and others. The majority of its revenue gets derived from the sale of pharmaceutical goods.

Zim Laboratories (BOM:541400) Headlines

No Headlines